Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France

Journal of Clinical Microbiology

Volumn 38, Issue 2, 2000, Pages 620-624

  Gambarotto, Karine ^b   Ploy, Marie Cécile ^b   Turlure, Pascal ^b   Grélaud, Carole ^b   Martin, Christian ^b   Bordessoule, Dominique ^b   Denis, Francois ^a  

^a Chu de Limoges   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; AGRICULTURE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CARRIER; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; FECES ANALYSIS; FEMALE; FRANCE; HOSPITAL PATIENT; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS TAURUS; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; NEGIBACTERIA;

EID: 0033961385     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.2.620-624.2000     Document Type: Article

References (39)

1. Aarestrup, F. M. 1905. Occurrence of glycopeptide resistance among E. faecium isolates from conventional and ecological poultry farms. Microb. Drug Resist. 1:255-257.
2. Bates, J., J. Z. Jordens, and D. T. Griffiths. 1994. Farm animal as a putative reservoir for vancomycin-resistant enterococcal infection in man. J. Antimicrob. Chemother. 34:507-516.
3. Boisivon, A., M. Thibault, and R. Leclercq. 1997. Colonization by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals. Clin. Microbiol. Infect. 3:175-179.
4. Cavallo, J. D., E. Hernandez, P. Bouchard, H. Debuysere, and Y. Buisson. 1997. Portage asymptomatique d'entérocoques résistants à la vancomycine en France. Presse Med. 26:807.
5. Centers for Disease Control and Prevention. 1993. Nosocomial enterococci resistant to vancomycin - United States. 1989-1993. Morbid. Mortal. Weekly Rep. 42:597-599.
6. Chaslus-Dancla, E., and J. L. Martel. 1997. Résistance aux antibiotiques chez les animaux d'élevage. Bull. Soc. Fr. Microbiol. 12:152-159.
7. Comité de l'Antibiogramme de la Société Française de Microbiologie. 1998. Communiqué 1998 du Comité de l'Antibiogramme de la Société Française de Microbiologie. Pathol. Biol. 46:I-XVI.
8. Coque, T. M., J. F. Tomayko, S. C. Ricke, P. C. Okhyusen, and B. E. Murray. 1996. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob. Agents Chemother. 40: 2605-2609.
9. Currie, B. P., S. Gnass, and M. H. Levi. 1996. A hospital-based rectal swab culture survey to detect vancomycin-resistant enterococci: utility and application. Int. J. Infect. Dis. 1:87-91.
10. Dukta-Malen, S., S. Evers, and P. Courvalin. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33:24-27.
11. Endtz, H. P., N. Van den Braak, A. Van Belkum, J. A. J. W. Kluytmans, J. G. M. Koeleman, L. Spanjaard, A. Voss, A. J. L. Weesink, C. M. J. E. Vandenbroucke-Grauls, A. G. M. Buitting, A. Van Duin, and H. A. Verbrugh. 1997. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J. Clin. Microbiol. 35:3026-3031.
12. Fontana, R., M. Boaretti, A. Grossato, E. A. Tonin, M. M. Lleo, and G. Satta. 1990. Paradoxical response of E. faecalis to the bactericidal activity of penicillin is associated with reduced activity of one autolysine. Antimicrob. Agents Chemother. 34:314-320.
13. Ford, M., J. D. Perry, F. K. Gould, and K. E. Orr. 1996. Neomycin blood agar as a selective medium for vancomycin resistant Enterococcus faecium. J. Clin. Pathol. 49:437-438.
14. Frieden, T. R., S. S. Munsiff, D. E. Low, B. M. Willey, G. Williams, Y. Faur, W. Eisner, S. Warren, and T. H. Kreiswir. 1993. Emergence of vancomycin-resistant enterococci in New York City. Lancet 342:76-79.
15. Glenn Moris, J., D. K. Shay, J. N. Hebden, R. J. McCarter, Jr., B. E. Perdue, W. Jarvis, J. A. Johnson, T. C. Dowling, L. B. Polish, and R. S. Schwalbe. 1995. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann. Intern. Med. 123:250-259.
16. Gordts, B., H. Van Landuyt, M. Ieven, P. Vandamme, and H. Goossens. 1995. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J. Clin. Microbiol. 33:2842-2846.
17. Guerin, F., J. D. Perrier-Gros-Claude, V. Foissaud, T. Masseron, and J. Thierry. 1998. Entérocoques résistants à la vancomycine en France. Haute prévalence dans une population ambulatoire de sujets jeunes. Presse Med 27:1427-1429.
18. Handwerger, S., B. Raucher, D. Altarac, J. Monka, S. Marchione, K. V. Singh, B. Murray, J. Wolff, and B. Walters. 1993. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin. Infect. Dis. 16:750-755.
19. Jordens, J. Z., J. Bates, and D. T. Griffiths. 1994. Fecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J. Antimicrob. Chemother. 34:515-528.
20. Kaplan, R. R., P. H. Gilligan, and R. R. Facklam. 1988 Recovery of resistant enterococci during vancomycin prophylaxis. J. Clin. Microbiol. 26:1216-1218.
21. Kjerulf, A., L. Pallesen, and H. Westh. 1996. Vancomycin-resistant enterococci at a large university hospital in Denmark. APMIS 104:475-479.
22. Klare, I. 1995. vanA-mediated high-level glycopeptide resistance in E. faecium from husbandry. FEMS Microbiol. Lett. 125:165-172.
23. Klare, I., H. Heier, H. Claus, G. Bohme, S. Marin, G. Seltmann, R. Hakenbeck, V. Antanassova, and W. Witte. 1995. E. faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animals foodstuffs and fecal samples of humans in the community. Microb. Drug Resist. 1:265-272.
24. Leclercq, R., E. Derlot, J. Duval, and P. Courvalin. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in E. faecium. N. Engl. J. Med. 319:157-161.
25. Matushek, M., S. Slaughter, T. Rice, and R. Weinstein. 1996. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 348:1615-1619.
26. McDonald, L. C., M. J. Kuehnert, F. C. Tenover, and W. J. Jarvis. 1997. Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. Emerg. Infect. Dis. 3:311-317.
27. Montecalvo, M. A., H. De Lencastre, M. Carraher, C. Gedris, M. Chung, K. Vanhorn, and G. P. Wormser. 1995. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect. Control Hosp. Epidemiol. 16:680-685.
28. Murray, B. E. 1990. The life and times of the Enterococcus. Clin. Microbiol. Rev. 3:46-65.
29. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial susceptibility tests. Approved standard M2-A6. National Committee for Clinical Laboratory Standards. Wayne, Pa.
30. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards. Wayne, Pa.
31. Perichon, B., P. Reynolds, and P. Courvalin. 1997. VanD-type glycopeptide-resistant Enterococcus, faecium BM4339. Antimicrob. Agents Chemother. 41:2016-2018.
32. Perlada, D. E., A. G. Smulian, and M. T. Cushion. 1997. Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati. Ohio: a prospective citywide survey. J. Clin. Microbiol. 35:2342-2347.
33. Schmidt, J. L., R. Leclercq, A. Scheimberg, and D. Landauer. 1994. Approche épidémiologique et clinique des entérocoques: résultats d'une enquête. Med. Mal. Infect. 24(spécial):141-148.
34. Silverman, J., L. A. Thal, M. B. Perri, G. Bostic, and M. J. Zervos. 1998. Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci. J. Clin. Microbiol. 36:830-832.
35. Vandamme, P., E. Vercauteren, C. Lammens, N. Pensart, M. Ieven, B. Pot, R. Leclercq, and H. Goossens. 1996. Survey of enterococcal susceptibility patterns in Belgium. J. Clin. Microbiol. 34:2572-2576.
36. Van der Auwera, P., N. Pensart, V. Korten, B. E. Murray, and R. Leclercq. 1996. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J. Infect. Dis. 173: 1129-1136.
37. Van Horn, K. G., C. A. Gedris, and K. M. Rodney. 1996. Selective isolation of vancomycin-resistant enterococci. J. Clin. Microbiol. 34:924-927.
38. Weinstein, J. W., M. Roe, M. Towns, L. Sanders, J. J. Thorpe, G. R. Corey, and D. J. Sexton. 1996. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect. Control Hosp. Epidemiol. 17:36-41.
39. Wells, C. L., B. A. Juni, S. B. Cameron, K. R. Mason, D. L. Dunn, P. Ferrieri, and F. S. Rhame. 1995. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin. Infect. Dis. 21:45-50.